It promotes the proliferation, invasion, and epithelial-mesenchymal transition (EMT) of HCC by catalyzing the trimethylation of histone H3 at lysine 27 (H3K27me3) to silence tumor suppressor genes, such as CDKN2A and PTEN10. The gene discussed is CDKN2A; the disease is neoplasm.